Product Details
LenVat 4 – Lenvatinib Capsules 4 mg In Pakistan
LenVat 4 contains lenvatinib 4mg, an oral kinase inhibitor used as part of specialist treatment for certain cancers. Depending on the cancer type and treatment plan, lenvatinib may be used for differentiated thyroid cancer, hepatocellular carcinoma, advanced renal cell carcinoma, and certain advanced endometrial cancers. It may be prescribed alone or in combination with medicines such as pembrolizumab or everolimus.
Benefits
- Cancer Treatment: Used in approved treatment plans for certain cancers.
- Thyroid Cancer: Used for specific radioactive-iodine-refractory differentiated thyroid cancers.
- Kidney Cancer: Can be used with pembrolizumab or everolimus for certain advanced renal cell carcinomas.
- Liver Cancer: Used for unresectable hepatocellular carcinoma.
- Targeted Therapy: Works by inhibiting kinase signaling involved in cancer-cell growth and tumor blood-vessel formation.
Specifications
| Specification | Details |
|---|---|
| Product Name | LenVat 4 |
| Active Ingredient | Lenvatinib |
| Strength | 4mg |
| Dosage Form | Hard Capsule |
| Drug Class | Kinase Inhibitor |
| Route | Oral |
| Main Uses | Certain thyroid, kidney, liver & endometrial cancers |
| Prescription Status | Prescription-only medicine |
| Storage | Store according to the manufacturer's instructions |
Lenvatinib is available in 4mg and 10mg capsule strengths in the referenced prescribing information.
How To Use
- Take LenVat exactly according to the oncologist's prescription.
- Lenvatinib is generally taken once daily, with or without food, at approximately the same time each day.
- Swallow capsules whole; do not crush or chew them.
- If swallowing capsules is difficult, the medicine may be prepared in water or apple juice according to the manufacturer's specific instructions.
- If a missed dose cannot be taken within 12 hours of the scheduled time, skip it and take the next dose at the normal time.
- Do not change the dose or stop treatment without consulting your oncologist. Dose interruptions or reductions may be required for certain adverse reactions.
Why Choose LenVat 4?
- Contains 4mg of lenvatinib, an established targeted anticancer medicine.
- Available as a convenient oral capsule.
- Used in evidence-based treatment protocols for several specific cancers.
- Can be incorporated into individualized treatment plans, including combination therapy where indicated.
- The 4mg strength can be useful when a physician prescribes a lower or adjusted daily dose.
